Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the month of April 2021, with the report dated April 9, 2021. The document serves as a transaction notification regarding share acquisitions by Persons Discharging Managerial Responsibilities (PDMRs) and Persons Closely Associated (PCAs) under the Company's Share Reward Plan.
Key Financial Metrics
The filing does not contain consolidated financial statements, revenue, profit, cash flow, margin, debt, or liquidity metrics for the Company. It exclusively details specific share transactions executed on April 8, 2021.
| Transaction Type | Instrument | Price per Share | Total Volume | Exchange |
|---|---|---|---|---|
| Acquisition (Dividend Re-investment) | Ordinary Shares (25p each) | £13.1367 | 615 shares | London Stock Exchange (XLON) |
Note: The total volume of 615 shares is the aggregate of 13 individual transactions listed in the filing.
Material Changes
No material changes to the Company's financial position, operations, or strategy are reported in this filing. The document solely discloses routine compliance notifications for share acquisitions resulting from dividend re-investments.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or contingencies. It is a statutory disclosure of insider trading activity compliant with regulatory requirements.
Key Facts for Investor Verification
- Transaction Nature: All reported transactions were acquisitions of Ordinary Shares via dividend re-investment, not open market purchases or sales.
- Participants: Transactions involved 13 senior executives, including the CEO (Ms E Walmsley), President of Global Vaccines (Mr R Connor), and President of Global Pharmaceuticals (Mr L Miels).
- Timing and Price: All transactions occurred on April 8, 2021, at a uniform price of £13.1367 per share.
- Scope: This filing does not provide data on GSK's overall financial performance for the period; investors should refer to Form 20-F or quarterly earnings releases for that information.